United States· US:49643-015_36ad1e17-751d-e226-e063-6394a90ab328
Horse Epithelia
A medicinal product containing equus caballus skin, registered in United States by Allermed Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- EQUUS CABALLUS SKIN
- Manufacturer
- Allermed Laboratories, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1149643-015-30
- ndc1149643-015-05
- ndc1149643-015-50
- ndc1149643-015-10
- ndc1149643015055 mL in 1 VIAL, MULTI-DOSE (49643-015-05)
- ndc11496430151010 mL in 1 VIAL, MULTI-DOSE (49643-015-10)
- ndc11496430153030 mL in 1 VIAL, MULTI-DOSE (49643-015-30)
- ndc11496430155050 mL in 1 VIAL, MULTI-DOSE (49643-015-50)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Equus caballus skin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Prick-Testlösung Pferdeepithelien, Provokations-Testlösung Pferdeepithelien
- Hungary · Alyostal Prick Állati Eredetű Allergének
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea9534ff-115d-45c9-b5d1-7e371b06ccb9 GET /v1/drugs/ea9534ff-115d-45c9-b5d1-7e371b06ccb9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "CUTANEOUS; INTRADERMAL; SUBCUTANEOUS",
"source": "ndc",
"strength": ".1",
"substance": "EQUUS CABALLUS SKIN",
"productndc": "49643-015",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "g/mL",
"application_number": "BLA102211",
"marketing_category": "BLA"
}See everything about equus caballus skin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.